Privine (Insight Pharmaceuticals LLC)


Welcome to the PulseAid listing for the Privine drug offered from Insight Pharmaceuticals LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Insight Pharmaceuticals LLC
NON-PROPRIETARY NAME: Naphazoline Hydrochloride
SUBSTANCE NAME: NAPHAZOLINE HYDROCHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: NASAL
DOSAGE FORM: SUSPENSION/ DROPS
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2009-07-16
END MARKETING DATE: 0000-00-00


Privine HUMAN OTC DRUG Details:

Item DescriptionPrivine from Insight Pharmaceuticals LLC
LABELER NAME: Insight Pharmaceuticals LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 0.125(mL/25mL)
START MARKETING DATE: 2009-07-16
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63736-663_8541b271-ccd6-4c6d-9797-60335e7e4d22
PRODUCT NDC: 63736-663
APPLICATION NUMBER: part341

Other NAPHAZOLINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.Naphazoline
Insight PharmaceuticalsPrivine
Insight Pharmaceuticals LLCPrivine
International Nature NutraceuticalsPi Yen Chin
Preferred Pharmaceuticals, Inc.AK-Con
Proficient Rx LPNaphazoline
Rebel Distributors Corp.AK-Con
Sato Pharmaceutical Co., Ltd.Sato Clear